Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Ultra-Fast Autologous CD19-targeted Chimeric Antigen Receptor T (CAR- T) Therapy for Refractory Systemic Lupus Erythematosus

NCT07233642 is registered in ClinicalTrials.gov with The Children's Hospital of Zhejiang University School of Medicine as lead sponsor.

NCT NCT07233642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07233642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Ultra-Fast Autologous CD19-targeted Chimeric Antigen Receptor T (CAR- T) Therapy for Refractory Systemic Lupus Erythematosus
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine
Phase
Phase 1
Overall status
Recruiting
Start date
November 30, 2025
Completion date
September 30, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus